REFERENCES
  1. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J2018;39 :3021–3104.
  2. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA2013;310 :959–968.
  3. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord2017;16 :21.
  4. Cabello-Verrugio C, Morales MG, Rivera JC, Cabrera D, Simon F. Renin-angiotensin system: an old player with novel functions in skeletal muscle. Med Res Rev 2015;35 :437–463.
  5. Kara M, Kaymak B, Ata AM, et al. SONOGRAPHIC THIGH ADJUSTMENT RATIO - STAR A Golden Formula for the Diagnosis of Sarcopenia. Am J Phys Med Rehabil 2020. doi:10.1097/PHM.0000000000001439 [Epub ahead of print]
  6. Pinheiro PA, Carneiro JA, Coqueiro RS, Pereira R, Fernandes MH. ”Chair Stand Test” as Simple Tool for Sarcopenia Screening in Elderly Women. J Nutr Health Aging 2016;20 :56–59.
  7. Özçakar L, Kara M, Quittan M, Ata AM, Michail X, Kaymak B. The need for an integrative musculoskeletal approach in sarcopenia: the ISarcoPRM kickstart. Eur J Phys Rehabil Med2020. doi:10.23736/S1973-9087.20.06255-3 [Epub ahead of print]
  8. Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One2014;9 :e113637.
  9. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020;21 :300–307.e2.
  10. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115 :92–106.
  11. Pacifico J, Geerlings MAJ, Reijnierse EM, Phassouliotis C, Lim WK, Maier AB. Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis. Exp Gerontol2020;131 :110801.
  12. Castillo-Olea C, Garcia-Zapirain Soto B, Zuñiga C. Evaluation of Prevalence of the Sarcopenia Level Using Machine Learning Techniques: Case Study in Tijuana Baja California, Mexico. Int J Environ Res Public Health 2020;17 :1917.
  13. Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One2014;9 :e86902.
  14. Park SH, Park JH, Song PS, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens2013;7 :420–425. doi:10.1016/j.jash.2013.06.002
  15. Ata AM, Kara M, Kaymak B, Özçakar L. Sarcopenia is not ’Love’: You Have to Look Where You Lost it! Am J Phys Med 2020. doi:10.1097/PHM.0000000000001391 [Epub ahead of print]
  16. Abe T, Sakamaki M, Yasuda T, Bemben MG, Kondo M, Kawakami Y, Fukunaga T. Age-related, site-specific muscle loss in 1507 Japanese men and women aged 20 to 95 years. J Sports Sci Med2011;10 :145-50.
  17. Burton LA, McMurdo ME, Struthers AD. Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?. Clin Endocrinol (Oxf) 2011;75 :725–729.
  18. Fonseca Alves DJ, Bartholomeu-Neto J, Júnior ER, Ribeiro Zarricueta BS, Nóbrega OT, Córdova C. Walking Speed, Risk Factors, and Cardiovascular Events in Older Adults-Systematic Review. J Strength Cond Res 2017;31 :3235–3244.
  19. Dumurgier J, Elbaz A, Dufouil C, Tavernier B, Tzourio C. Hypertension and lower walking speed in the elderly: the Three-City study. J Hypertens 2010;28 :1506-14.
  20. Zhang X, Huang L, Peng X, et al. Association of handgrip strength with hypertension among middle-aged and elderly people in Southern China: A cross-sectional study. Clin Exp Hypertens2020;42 :190–196.
  21. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, Skinner JS. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009;41 :1510-30.
  22. Miszko TA, Cress ME, Slade JM, Covey CJ, Agrawal SK, Doerr CE. Effect of strength and power training on physical function in community-dwelling older adults. J Gerontol A Biol Sci Med Sci2003;58 :171-5.
  23. Onder G, Penninx BW, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 2002;359 :926–930.
  24. Buford TW, Manini TM, Hsu FC, et al. Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise. J Am Geriatr Soc 2012; 60 : 1244-52.
  25. Sumukadas D, Band M, Miller S, et al. Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial. J Gerontol A Biol Sci Med Sci2014; 69 : 736-43.
  26. Baptista LC, Machado-Rodrigues AM, Veríssimo MT, et al. Exercise training improves functional status in hypertensive older adults under angiotensin converting enzymes inhibitors medication. Exp Gerontol 2018; 109 : 82-9.
  27. Coelho-Júnior HJ, Gambassi BB, Irigoyen MC, et al. Hypertension, Sarcopenia, and Global Cognitive Function in Community-Dwelling Older Women: A Preliminary Study. J Aging Res2018;2018 :9758040.
  28. Takeshita H, Yamamoto K, Mogi M, Nozato S, Horiuchi M, Rakugi H. Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice. Hypertens Res2020;43 :296–304.
  29. Di Bari M, van de Poll-Franse LV, Onder G, et al. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc2004;52 :961–966.
  30. Wicklmayr M, Dietze G, Brunnbauer H, Rett K, Mehnert H. Dose-dependent effect of bradykinin on muscular blood flow and glucose uptake in man.Hoppe Seylers Z Physiol Chem 1983;364 :831–833.
  31. Popadic Gacesa JZ, Momcilovic M, Veselinovic I, Brodie DA, Grujic NG. Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men. BMC Musculoskelet Disord 2012;13 :217.